A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature review
Feng Jin,1 Hui Zhu,2 Li Kong,2 Jinming Yu2 1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, University of Jinan, Jinan, People’s Republic of China; 2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Ji...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/a-spectrum-of-cutaneous-toxicities-from-erlotinib-may-be-a-robust-clin-peer-reviewed-article-OTT |